NCT03236233

A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

A Randomised, Single-blind, Placebo-controlled, Dose-escalation Study to Assess the Safety and Tolerability of Single and Repeat, Inhaled Doses of PC786 in Healthy Subjects Combined With a Randomised, Single-blind, Placebo-controlled, Parallel Group to Assess the Safety and Tolerability of a Single Dose of Inhaled PC786 in Subjects With Mild Asthma

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 39 (actual)
• Sponsor: Pulmocide Ltd · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study investigates the safety, tolerability and pharmacokinetics of single and repeat doses of PC786.

Conditions

• Respiratory Syncytial Virus (RSV)

Interventions

Type	Name	Description
DRUG	PC786 - Single doses	Safety and tolerability of single doses
DRUG	Placebo - Single doses	Safety and tolerability of single doses
DRUG	PC786 - Repeat doses	Safety and tolerability of repeat doses
DRUG	Placebo - Repeat doses	Safety and tolerability of repeat doses

Timeline

• Start date: 2017-06-21
• Primary completion: 2017-12-15
• Completion: 2017-12-15
• First posted: 2017-08-01
• Last updated: 2017-12-21

Locations

1 site across 1 country: United Kingdom